SCHEMBL11409263

SCHEMBL11409263

CCCCCCCCCCC(C)n1ccc(C(=O)O)n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.43
CYP2C19 P33261 1/20 0.43
PLA2G4A P47712 2/20 0.42
MAPT P10636 2/20 0.39
LMNA P02545 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
HCAR2 Q8TDS4 1/20 0.38
ACE2 Q9BYF1 1/20 0.37
GPR84 Q9NQS5 3/20 0.37
FFAR1 O14842 1/20 0.37
KDM4E B2RXH2 1/20 0.36
MEN1 O00255 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
PKM P14618 1/20 0.36
ALOX15 P16050 1/20 0.36
TSHR P16473 1/20 0.36
NFKB1 P19838 1/20 0.36
THPO P40225 1/20 0.36
BLM P54132 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20898646 0.74 ADA (0.36) ALDH1A1CYP2C19MAPTLMNAGPR84
SCHEMBL11365598 0.73 PLA2G4A (0.54) ALDH1A1CYP2C19PLA2G4AMAPTLMNA
SCHEMBL18158115 0.72 SMN1; SMN2 (0.39) ALDH1A1SMN1; SMN2HCAR2KDM4EMEN1
SCHEMBL27793505 0.71 PLA2G4A (0.52) ALDH1A1CYP2C19PLA2G4AMAPTLMNA
SCHEMBL22748596 0.70 ALDH1A1 (0.41) ALDH1A1CYP2C19PLA2G4AMAPTLMNA
SCHEMBL17288867 0.69 PLA2G4A (0.50) ALDH1A1CYP2C19PLA2G4AMAPTLMNA
SCHEMBL298871 0.68 SMN1; SMN2 (0.37) LMNASMN1; SMN2KDM4EALOX15TSHR
SCHEMBL27166351 0.68 PLA2G4A (0.41) PLA2G4AHCAR2FFAR1TDP1
SCHEMBL18158114 0.67 MME (0.40) PLA2G4AMAPTSMN1; SMN2MEN1KMT2A
SCHEMBL20762674 0.66 KMT2A (0.41) ALDH1A1MAPTLMNASMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0029363-A1 Pyrazole derivatives, process for their preparation and pharmaceutical compositions containing them MORISHITA PHARMACEUTICAL CO. LTD. (JP) 1981-05-27 EP disclosed